THE CHINESE UNIVERSITY OF HONG KONG

Their core work

The Chinese University of Hong Kong (CUHK) is a major research university contributing specialized expertise to European collaborative projects across a surprisingly diverse range of fields — from manufacturing ergonomics and medical microrobotics to fundamental particle physics. In H2020, CUHK participates exclusively as a third-party contributor through MSCA mobility and staff exchange programmes, bringing non-European research perspectives to EU consortia. Their contributions span applied industrial research (smart manufacturing, drug delivery systems) and fundamental science (gravitational waves, dark matter), reflecting the breadth of a large multidisciplinary university.

What they specialise in

How they've shifted over time

CUHK's earliest H2020 involvement (2016) centred on advanced materials through perovskite optoelectronics. By 2020, their participation shifted toward applied domains — smart manufacturing with collaborative robots and medical microrobotics for drug delivery. Their most recent project (2022) moves into fundamental physics, suggesting the university's different research groups are independently connecting with European networks rather than following a single strategic trajectory.

CUHK's H2020 participation is broadening across unrelated fields, suggesting growing institutional appetite for EU collaboration rather than a single deepening specialization.

How they like to work

CUHK joins exclusively as a third-party contributor — never as coordinator or direct consortium partner — which is typical for non-EU institutions participating through MSCA exchange and fellowship programmes. Despite this peripheral role, they have connected with 57 unique partners across 18 countries, indicating broad but shallow network ties. Working with CUHK means accessing a large Asian research university's facilities and talent through structured staff exchange, not deep co-development partnerships.

Through just 4 projects, CUHK has touched 57 partners in 18 countries — a wide but thin network built through large MSCA-RISE staff exchange consortia rather than repeated deep collaborations.

What sets them apart

CUHK offers EU consortia a gateway to Hong Kong's research ecosystem — one of Asia's strongest — through MSCA mobility frameworks. Their value lies in providing non-European research perspectives and access to Asian industry networks, particularly relevant for projects needing global validation or Asia-Pacific deployment pathways. For consortium builders, adding CUHK strengthens the international dimension of proposals without requiring direct EU funding allocation to a non-associated country.

Highlights from their portfolio

• MAMBO
  Combines microrobotics, magnetic swarm control, and medical imaging for a concrete clinical application — liver chemoembolization — making it the most commercially translatable project in CUHK's portfolio.
• PROBES
  Ambitious scope spanning from particle physics to gravitational wave detection, connecting CUHK to Europe's largest physics research networks through 2026.